Buy DAFALGAN 1G Paracetamol 8 TABLETS for sale in your approved pharmacy. DAFALGAN is a paracetamol drug indicated for the symptomatic treatment of mild to moderate pain and / or febrile conditions.
For warnings, precautions for use and contraindications, please consult the instructions for use of Dafalgan 1G / 1000mg.
DAFALGAN 1g is a vignette medicine indicated for the symptomatic treatment of pain of mild to moderate intensity and / or febrile states.
What is fever ?
Fever is a rise in body temperature above normal (> 37.5 ° C in the morning,> 38 ° C in the evening) in the absence of intense physical activity, in a normally covered person, in an atmosphere temperate.
What is the mechanism of fever ?
Our brain has a temperature regulation center that functions like a central thermostat. When all is well, this thermostat indicates an average temperature of 37 ° C.
In case of infection, our body needs a higher temperature to trigger its immune defense mechanisms. It then produces molecules called prostaglandins which increase the reference temperature of our thermostat.
What to do in case of fever ?
Dosage and route of administration
DAFALGAN 1 g film-coated tablet is reserved for adults and children over 15 years of age (over 50 kg). For adults and children over 15 years of age, use 1 tablet of DAFALGAN 1 g to be renewed every 4 hours, without exceeding 4 tablets per day. Oral use.
Dafalgan 1G Paracetamol contains: PARACETAMOL (DCI) 1 G. EXCIPIENTS: HYPROMELLOSIS; POVIDONE; CROSCARMELLOSIS SODIUM; MICROCRYSTALLINE CELLULOSE; GLYCEROL BEHENATE; MAGNESIUM STEARATE; COLLOIDAL ANHYDROUS SILICA; OPADRY-OY-S-38901; (HYPROMELLOSIS; TITANIUM DIOXIDE; PROPYLENE GLYCOL); INDIGOTINE ALUMINIC LACQUER; QSP 1 FILM TABLET.
Allergy to paracetamol or other constituents; hepatocellular insufficiency. DAFALGAN 1 g film-coated tablet is a medicine containing paracetamol. It is essential to avoid overdose by checking the absence of paracetamol in the composition of other drugs. The maximum recommended dose should not be exceeded. DAFALGAN 1 g film-coated tablet is contraindicated in children before 15 years of age. DAFALGAN 1 g film-coated tablet is possible during pregnancy and lactation under normal conditions of use.
Blister 8 tablets
Attention, the drug Dafalgan 1G / 1000mg is not a product like the others. Read the package leaflet carefully before ordering. Keep medicines out of the reach of children. If symptoms persist, seek the advice of your doctor or pharmacist. Beware of incompatibilities on your current products.
Pharmacovigilance Report an adverse drug reaction(s)
ANSM - Updated on : 02/01/2025
DAFALGAN 1000 mg, film-coated tablet
Paracetamol
Always take this medicine exactly as instructed in this leaflet or by your doctor or pharmacist.
- Keep this leaflet. You may need to read it again.
- Ask your pharmacist for any advice or information you may need.
- If you experience any side effects, talk to your doctor or pharmacist. This also applies to any side effects not mentioned in this leaflet. See section 4.
- You should contact your doctor if pain persists for more than 5 days, or fever for more than 3 days, or if there are any other signs of insufficient efficacy.
What does this leaflet contain?
1. What is DAFALGAN 1000 mg, film-coated tablet and what is it used for?
2. What do I need to know before taking DAFALGAN 1000 mg, film-coated tablet?
3. How do I take DAFALGAN 1000 mg, film-coated tablet?
4. What are the possible side effects?
5. How do I keep DAFALGAN 1000 mg, film-coated tablet?
6. Package contents and other information.
1. WHAT IS DAFALGAN 1000 mg, film-coated tablet AND WHAT IS IT USED FOR?
Pharmacotherapeutic class: OTHER ANALGESICS and ANTIPYRETIC-ANILIDES - ATC code: N02BE01.
It is indicated for adults and children weighing 50 kg or more (around 15 years of age) to reduce fever and/or relieve mild to moderate pain (e.g. headaches, flu-like symptoms, toothache, aches and pains, painful menstruation, painful flare-ups of arthrosis).
Carefully read "Dosage" in section 3.
For children under 50 kg, other paracetamol presentations are available: ask your doctor or pharmacist for advice.
2. WHAT DO I HAVE TO KNOW BEFORE TAKING DAFALGAN 1000 mg, film-coated tablet?
Never take DAFALGAN 1000 mg, film-coated tablet:
- if you are allergic to paracetamol or any of the other ingredients of this medicine, as listed in section 6.
- if you have severe liver disease.
If in doubt, ask your doctor or pharmacist for advice.
Warnings and precautions
Talk to your doctor or pharmacist before taking DAFALGAN 1000 mg, film-coated tablet:
- if you are an adult weighing less than 50 kg,
- if you have kidney or liver disease,
- if you are elderly,
- if you regularly drink alcohol or have recently stopped drinking alcohol,
- in cases of chronic malnutrition, fasting, emaciation, anorexia or cachexia (low reserves or hepatic glutathione deficiency),
- in cases of dehydration,
- in case of Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency (may lead to hemolytic anemia),
- in Gilbert's syndrome (non-hemolytic familial jaundice).
In the event of acute viral hepatitis, discontinue treatment and consult your doctor.
Long-term, incorrect and/or high-dose use of this drug in patients with chronic headaches may cause headaches to develop or worsen. Do not increase your dose of painkillers, but consult your doctor.
During treatment with DAFALGAN 1000 mg, film-coated tablet, inform your doctor immediately:
- If you have any serious medical conditions, including severe kidney failure or sepsis (when bacteria and their toxins circulate in the blood, causing organ damage), or if you are malnourished, chronically alcoholic or also taking flucloxacillin (an antibiotic). A serious condition called metabolic acidosis (an abnormality of the blood and fluids) has been reported in patients who regularly take paracetamol for a prolonged period or who take paracetamol in combination with flucloxacillin. Symptoms of metabolic acidosis may include: severe breathing difficulties with rapid, deep breathing, drowsiness, nausea and vomiting.
Children and adolescents
In children being treated with paracetamol, the combination with another fever-reducing drug (antipyretic) is justified only if it is effective. The combination should only be initiated and monitored by a physician.
Other medicines and DAFALGAN 1000 mg, film-coated tablet
Inform your doctor or your pharmacist if you are taking, have recently taken or could be taking any other medicine, including one obtained without a prescription.
This medicine contains paracetamol. Other medicines contain paracetamol.
Check that you are not taking any other medicines containing paracetamol, including medicines obtained without a prescription.
Do not combine them, so as not to exceed the recommended daily dose.
Consult your doctor or your pharmacist :
- if you are taking any medicines that are potentially toxic to the liver. The toxicity of paracetamol may be increased.
- if you or your child have been prescribed a uric acid or blood sugar test, as this medicine may alter the results.
- (oral anticoagulants ). A doses, DAFALGAN 1000 mg, film-coated tablet may increase the action of your anticoagulant. If necessary, your doctor will adjust the dosage of your anticoagulant.
- if you are taking flucloxacillin (antibiotic), as there is a serious risk of blood and fluid abnormalities (known as metabolic acidosis), which must be treated as an emergency (see section 2).
DAFALGAN 1000 mg, film-coated tablet with alcohol
The consumption of alcoholic beverages during le treatment isnot recommended.
Pregnancy, breast-feeding and fertility
If you are pregnant or breastfeeding, think you might be pregnant or are planning a pregnancy, ask your doctor or pharmacist for advice before taking any medicine.
Pregnancy and breast-feeding
If required, this drug may be used during pregnancy and lactation.
You should use the lowest possible dose to relieve pain and/or fever, and take it for the shortest possible time. Contact your doctor if the pain and/or fever do not subside, or if you need to take the medication more frequently.
Fertility
It is possible that paracetamol may impair fertility in women, reversible on discontinuation of treatment.
Driving and use of machinery
Paracetamol has no or negligible effect on the ability to drive vehicles and use machines.
DAFALGAN 1000 mg, film-coated tablet contains less than 1 mmol (23 mg) sodium per film-coated tablet, i.e. it is essentially "sodium-free".
3. HOW DO I TAKE DAFALGAN 1000 mg, film-coated tablet?
Always take this medicine exactly as instructed in this leaflet, or as directed by your doctor or pharmacist. Check with your doctor or pharmacist if in doubt.
Dosage
For adults and children weighing 50 kg or more (approx. 15 years).
Use the lowest effective dose for the shortest possible duration. Use the 1000 mg dose for pain and/or fever not relieved by a 500 mg dose of paracetamol.
Dosage depends on weight; age is given for information only. If you don't know your child's weight, you should weigh him/her to determine the most appropriate paracetamol dosage. The recommended daily dose of paracetamol should be divided into several doses, without exceeding the maximum indicated in the table below.
|
Weight (approximate age) |
Maximum dose per dose |
Interval between two doses |
Maximum dose per day |
|
Adults and children over 50 kg (approx. 15 years) |
1000 mg or 1 g |
4 hours minimum |
3000 mg or 3 g (3 tablets) |
Caution: To avoid the risk of overdosing, check that paracetamol is not included in the composition of other medicines, including over-the-counter products. Respect the maximum recommended dose or the dose prescribed by your doctor : a higher dose will not relieve your pain any more, but may have serious consequences for your liver.
Adults weighing less than 50 kg, chronic malnutrition, dehydration, the elderly: ask your doctor or pharmacist for advice.
Hepatic insufficiency, chronic alcoholism and Gilbert's syndrome: never exceed 2000 mg (2 g) paracetamol per day.
Renal insufficiency: Dosage should be adapted to the degree of renal insufficiency. Consult your doctor before taking this medicine.
If you feel that the effect of this medicine is too strong or too weak, do not exceed the dose. Ask your doctor or pharmacist for advice.
Method of administration
Take by mouth.
Swallow the tablets as they are with a glass of water.
frequent use or prolonged use without medical supervision isnot recommended.
Unless medical advice is given, the duration of treatment is limited to 5 days in the case of pain and to 3 days in the case of fever.
If symptoms persist beyond, if worsen, or if new symptoms appear, stop treatment and consult your doctor immediately.
If you have taken more DAFALGAN 1000 mg, film-coated tablet than you should have
Stop treatment and consult your doctor or emergency physician immediately.
Overdose can be fatal.
Within the first 24 hours, the main symptoms of toxicity are nausea, vomiting, paleness, malaise, sweating, loss of appetite and abdominal pain.
If you forget to take DAFALGAN 1000 mg, film-coated tablet
Do not take a double dose to make up for the single dose you forgot to take.
If you stop taking DAFALGAN 1000 mg, film-coated tablet
Not applicable.
If you have any further questions about the use of this medicine, please ask your doctor or pharmacist.
4. WHAT ARE THE POSSIBLE SIDE EFFECTS?
Rare adverse reactions: may affect up to 1 in 1,000 people.
- skin redness, rash, urticaria. Stop taking paracetamol immediately, tell your doctor and never take paracetamol again.
- blood spots on the skin (purpura). Stop treatment immediately and inform your doctor. Treatment may be reintroduced only on the advice of your doctor.
- diarrhea, abdominal pain.
Very rare side effects: may affect up to 1 in 10,000 people.
- severe skin reactions. Treatment should be stopped immediately, your doctor informed, and paracetamol-containing drugs should never be taken again.
- biological changes requiring blood tests: abnormally low levels of certain white blood cells (leukopenia, neutropenia) or of certain blood cells such as platelets (thrombocytopenia), which may lead to nose or gum bleeding. In this case, consult a physician.
Undesirable effects of undetermined frequency frequency cannot be estimated from available data
- skin rash or redness, or allergic reaction manifested by sudden swelling of the face and neck which may cause difficulty in breathing (angioedema), or by sudden malaise with a drop in blood pressure (anaphylactic shock). Stop taking paracetamol immediately, tell your doctor and never take paracetamol again.
- Rounded, itchy, red patches of rash with a burning sensation, leaving coloured spots which may reappear in the same places if the drug is taken again (erythema pigmentum fixata), difficulty in breathing (bronchospasm), particularly if you have already experienced difficulty in breathing with other drugs such as non-steroidal anti-inflammatory drugs or acetylsalicylic acid. In this case, consult a physician.
- a serious condition which can cause the blood to become more acidic (known as metabolic acidosis), in patients with serious illnesses taking paracetamol (see section 2).
Reporting side effects
If you experience any side effects, please tell your doctor, pharmacist or nurse. This also applies to any side effects not mentioned in this leaflet. You can also report adverse reactions directly via the national reporting system: Agence nationale de sécurité du médicament et des produits de santé (ANSM) and the network of Centres Régionaux de Pharmacovigilance - Website: https://signalement.social-sante.gouv.fr/.
By reporting adverse reactions, you are helping to provide more information on drug safety.
5. HOW TO CONSERVE DAFALGAN 1000 mg, film-coated tablet?
Keep out of sight and reach of children.
Do not use this medicine after the expiration date indicated on the packaging. The expiration date refers to the last day of that month.
Tube: No special storage precautions.
Blister: Store at a temperature not exceeding 30°C, away from moisture.
Do not dispose of any medicine down the drain or with household waste. Ask your pharmacist to identify any medicines you no longer use. These measures will help protect the environment.
6. CONTENTS AND OTHER INFORMATION
What DAFALGAN 1000 mg film-coated tablet contains
- The active substance is :
Paracetamol................................................................................................................. 1000 mg
For one film-coated tablet.
- The other components are :
Hydroxypropylcellulose, Croscarmellose sodium*, Glycerol behenate, Magnesium stearate, Colloidal anhydrous silica. *See section 2.
Film coating :
Hypromellose (E464), polydextrose, calcium carbonate, medium-chain triglycerides.
What is DAFALGAN 1000 mg, film-coated tablet and what does it contain?
This medicine takes the form of a film-coated tablet.
Boxes of 8, 40 or 100 tablets.
Marketing authorization holder
3 RUE JOSEPH MONIER
92500 RUEIL-MALMAISON
Marketing authorization holder
3 RUE JOSEPH MONIER
92500 RUEIL-MALMAISON
304 avenue du docteur jean bru
47000 agen
or
UPSA SAS
979 AVENUE DES PYRENEES
47520 LE PASSAGE
Drug names in member states of the European Economic Area
Not applicable.
The last date on which this leaflet was revised was :
[to be completed subsequently by the holder]
{month YYYY}.
Detailed information on this drug is available on the ANSM (France) website.
Health education advice :
WHAT TO DO IN CASE OF FEVER :
Normal body temperature varies from person to person, and lies between 36.5°C and 37.5°C. A rise in temperature above 38°C can be considered a fever, but it is not advisable to treat fever with medication below 38.5°C.
This medicine is reserved for adults and children weighing 50 kg or more (approx. 15 years).
If the symptoms of fever are too troublesome, you can take this paracetamol-containing medicine at the recommended dosage.
To avoid the risk of dehydration, remember to drink frequently.
With this medication, fever should fall rapidly. Nevertheless :
- if other unusual signs appear,
- if fever persists for more than 3 days, or if it worsens,
- if headaches become severe, or if vomiting occurs,
CONSULTYOURDOCTOR IMMEDIATELY.
WHAT TO DO IN CASE OF PAIN :
The intensity of pain perception and the ability to resist it vary from person to person.
- Ifthere isno improvement after 5 days of treatment,
- if the pain is violent, unexpected and comes on suddenly (particularly a strong pain in the chest) and/or, on the contrary, recurs regularly,
- if it is accompanied by other signs such as general malaise, fever, unusual swelling of the painful area or reduced strength in a limb,
- if it wakes you up at night,
CONSULTYOURDOCTORIMMEDIATELY.
A drug interaction occurs when one or more effects of a drug are modified by another product. This interaction can occur with a food (grapefruit juice, liquorice), a drink (coffee or alcohol), a dietary supplement (the case of St John's wort and turmeric) or smoking. In this article, we explore the different types of effects that these products can have…
Read the article on the blogMyrrh, an age-old plant treasure, continues to captivate the world with its unique properties and fascinating history. This article explores the many facets of this precious resin, from its botanical extraction to its ancient and modern uses. Extracted from the Commiphora myrrha tree, a member of the Burseraceae family, myrrh is obtained from the gum-resin that runs off its bark.…
Read the article on the blogIn the past, feverfew was known as Chrysanthemum parthenium . If we have since kept its adjective, this chrysanthemum has disappeared in favor of a tanacetum which borders on tansy, while this previous substantive brought it closer to the vast tribe of "chrysanthemums" , a word forged thanks to two Greek roots: chrysos , "Gold" and anthemos , "flower". A little history Cazin , evoked a Matricaria parthenium , whose plate XXIV of the Reasoned Treaty immediately reassures…
Read the article on the blogRecently, significant progress has revolutionized knowledge of the pharmacology of cannabinoid derivatives. Synthetic cannabinoids such as PEA have been developed and an endocannabinoid system has been identified as well as the receptors and ligands that constitute it. Current clinical data strongly support the analgesic properties of cannabinoids on inflammatory and neuropathic pain. Focus on PEA (Palmitoyl Ethanol Amide) PEA is…
Read the article on the blogChronic fatigue syndrome or myalgic encephalomyelitis is classified as a rare disease and remains little known in France. The WHO has recognized this disease since 1993. The diagnosis requires a certain number of steps and meets strict criteria relating to the definition of chronic fatigue syndrome. How to detect chronic fatigue syndrome ? Myalgic encephalomyelitis is a chronic and complex…
Read the article on the blog
